Moneycontrol
SENSEX NIFTY
you are here:

Sarda Proteins Ltd.

BSE Live

Jun 30, 16:00
9.87 -0.51 (-4.91%)
Volume
AVERAGE VOLUME
5-Day
1,284
10-Day
2,532
30-Day
1,785
100
  • Prev. Close

    10.38

  • Open Price

    9.87

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Dec 27, 11:22
NT* 0.00 (0.00%)
Volume
No Data Available
0
  • Prev. Close

    -

  • Open Price

    -

  • Bid Price (Qty.)

    - (0)

  • Offer Price (Qty.)

    - (0)

Sarda Proteins is not listed on NSE

ANNOUNCEMENTS ON Sarda Proteins

  • Jun 30, 2020 12:42 Source: BSE

    Sarda Proteins - Closure of Trading Window

    Pursuant to the clause 4 of the schedule B of the Securities and Exchange Board of India (Prohibition of Insider Trading), Regulations, 2015 ("the Regulations") as amended by the Securities and Exchange Board of India (Prohibition of Insider Trading) (Amendment) Regulations, 2018 read with BSE Circular Ref No. UST/COMP/01/2019-20 dated 2nd April, 2019, the Trading Window for trading in the securities of the Company will remain closed for all the Insiders, Directors, Promoters and Designated employees of the Company from 01st July, 2020 till 48 hours after the announcement of the Un-audited financial results of the Company for the quarter ended as on 30th June, 2020.

  • Jun 19, 2020 17:50 Source: BSE

    Sarda Proteins - Audited Financial Results For The Quarter And Year Ended On 31St March, 2020

    In accordance with Regulations 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Audited Financial Results of the Company for the quarter and year ended on 31st March, 2020 along with Statement of Assets and Liabilities as on 31st March, 2020 and statement of cash flow for the year ended on 31st March, 2020 and Auditor''''s Report issued with unmodified opinion. Further, declaration in compliance with Regulation 33(3)(d) of Listing Regulations, read with SEBI Circular CIR/CFO/CMD/56/2016 dated May 27, 2016 is also enclosed herewith.

  • Jun 19, 2020 17:42 Source: BSE

    Sarda Proteins - Outcome Of The Board Meeting Held On Friday, 19Th June, 2020

    The Board of Directors of the Company in their meeting held on Friday, the 19th day of June, 2020, which commenced at 04:00 P.M. and concluded at 05:30 P.M. at the corporate office of the company situated at Inside Data Ingenious Global Limited, Station Road, Durgapura, Jaipur-302018 (Rajasthan)inter-alia, transacted the following business: 1. Approved the Audited Financial Results of the company for the quarter and year ended on 31st March, 2020 along with Statement of Assets and Liabilities as on 31st March, 2020 and statement of cash flow for the year ended on 31st March, 2020 (Enclosed herewith). 2. Took on record the Auditor''s Report (with unmodified opinion) on the Financial Results of the Company for the quarter and year ended on 31st March, 2020 (Enclosed herewith). Declaration in compliance with Regulation 33(3)(d) of Listing Regulations, read with SEBI Circular CIR/CFO/CMD/56/2016 dated May 27, 2016 is also enclosed herewith.

  • Jun 08, 2020 14:32 Source: BSE

    Sarda Proteins - Board Meeting Intimation for Board Meeting Intimation For Approval Of The Audited Financial Results For The Quarter And Year Ended On 31St March, 2020

    SARDA PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/06/2020 ,inter alia, to consider and approve Pursuant to the provisions of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby intimate that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, 19th June, 2020 at 04:00 P.M. at the corporate office of the company situated at Inside Data Ingenious Global Limited, Station Road, Durgapura, Jaipur-302 018 (Rajasthan) inter alia: i.To approve the Audited Financial Results of the company for the quarter and year ended on 31st March, 2020 along with Statement of Assets and Liabilities as on 31st March, 2020 and statement of cash flow for the year ended on 31st March, 2020. ii.To take on record the Auditor's Report thereon.

  • Jun 03, 2020 18:17 Source: BSE

    Sarda Proteins - Material Impact Of Covid-19 Pandemic On Company

    Pursuant to SEBI Circular No. SEBI/HO/CFD/CMD1/CIR/P/2020/84 dated May 20, 2020 and Regulation 30 of the Listing Regulations, please find enclosed as Annexure-1 the disclosure of the material impact of CoVID- 19 pandemic on the Company.

  • May 21, 2020 18:10 Source: BSE

    Sarda Proteins - Announcement under Regulation 30 (LODR)-Resignation of Director

    Disclosures pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''Listing Regulations")-Resignation of Director

  • May 12, 2020 17:34 Source: BSE

    Sarda Proteins - Compliance Certificate Under Regulation 40 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015

    We are enclosing herewith, Compliance Certificate under Regulation 40 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015 issued by M/s. V.M. & Associates, Practicing Company Secretaries, Jaipur for the half year ended on 31st March, 2020.

  • May 12, 2020 11:11 Source: BSE

    Sarda Proteins - Compliance Certificate Pursuant To Regulation 7(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 For The Half Year Ended On 31St March, 2020.

    Compliance Certificate under Regulation 7 (3) of the aforesaid Regulations for the half-year ended on 31st March, 2020. Kindly take the same on record.

  • May 08, 2020 15:29 Source: BSE

    Sarda Proteins - Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations").

    In furtherance to our letters dated March 24, 2020 and pursuant to regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015, we wish to inform you that, in line with the various directives being issued by the Central / State Governments and local authorities, the Company has started its operations at the Registered and Corporate Office situated in the State of Rajasthan with bare minimum staff in a phased manner.

  • May 07, 2020 12:22 Source: BSE

    Sarda Proteins - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Certificate under Regulation 74(5) of the Securities and Exchange Board of India (SEBI) (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March, 2020 received from M/s. Link Intime India Private Limited, Registrar and Share Transfer Agent of the Company.

BOARD MEETING

Meeting Date : Jun 19, 2020
Remark : Quarterly Results